The Conafay Group, LLC is a registered federal lobbying firm. For Q3 2026 it reported $390K across 13 client reports and lists 9 lobbyists across its filings. Issues include Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations and Manufacturing.
| Client | Reported | Issues |
|---|---|---|
| DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) | $80K | Health Issues |
| REVAGENIX, INC. | $50K | Health Issues, Medical/Disease Research/Clinical Labs |
| MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) | $50K | Budget/Appropriations, Medical/Disease Research/Clinical Labs |
| REALTA LIFE SCIENCES, INC. | $40K | Budget/Appropriations, Health Issues |
| BRIGHT PATH LABORATORIES, INC. | $40K | Medical/Disease Research/Clinical Labs |
| CHILD GENETIC SCREENING ALLIANCE | $40K | Budget/Appropriations, Medical/Disease Research/Clinical Labs |
| KIRIN BIOMATERIALS | $30K | Manufacturing |
| ELUSYS THERAPEUTICS, INC | $20K | Medical/Disease Research/Clinical Labs |
| AGILITI HEALTH INC. | $20K | Health Issues |
| CRESILON, INC. | $10K | Manufacturing, Medical/Disease Research/Clinical Labs |
| PKX BIO | $10K | Health Issues, Medical/Disease Research/Clinical Labs |
| ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE | $0 | Budget/Appropriations, Defense |
| CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP | $0 |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $1.10M | 14 |
| 2025 | $960K | 13 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.